MedPath

Effect of Fish Oil on Markers of the Metabolic Syndrome in Overweight Adolescent Boys

Not Applicable
Completed
Conditions
Metabolic Syndrome
Registration Number
NCT00929552
Lead Sponsor
University of Copenhagen
Brief Summary

The aim of the study is to investigate if dietary fish oil has a beneficial effect on blood pressure, insulin sensitivity, blood lipid profile, body composition and metabolic rate in healthy, but slightly overweight, teenage boys.

We hypothesized that the n-3 long chain polyunsaturated fatty acids from fish oil might have greater effect during growth and development, as intervention trials studying the effect of fish oil on babies have shown greater effects than in adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
78
Inclusion Criteria
  • Weight above the 90th percentile for height and age.
Exclusion Criteria
  • Smoking, severe illnesses.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Markers of the metabolic syndrome. Blood pressure, insulin sensitivity, HDL-cholesterol and triacylglycerol.Intervention period = 16 weeks
Secondary Outcome Measures
NameTimeMethod
Body composition16 weeks

Trial Locations

Locations (1)

Department of Human Nutrition

🇩🇰

Frederiksberg, Denmark

Department of Human Nutrition
🇩🇰Frederiksberg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.